Vardenafil oral jellies as a potential approach for management of pediatric irritable bowel syndrome
Abstract
Irritable bowel syndrome (IBS); a widespread disorder in gastrointestinal tract especially in children, burdens their healthcare systems and upsets families. Great attention was paid to understand the pathophysiological cause of disorder. However, developing a convenient treatment especially for children remains a challenge. Phosphodiesterase inhibitors were recently introduced for IBS management. Vardenafil (VDF), a phosphodiesterase-5...
Paper Details
Title
Vardenafil oral jellies as a potential approach for management of pediatric irritable bowel syndrome
Published Date
Sep 1, 2021
Journal
Volume
29
Issue
9
Pages
955 - 962
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History